NEURODERM
LIVE

Serial Number

79299574

Owner

Neuroderm LTD

Attorney

A. Tally Eitan

Filing Date

May 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NEURODERM Trademark

Serial Number: 79299574 • Registration: 6358631

NEURODERM is a trademark filed by Neuroderm LTD on May 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Neuroderm LTD (13 trademarks)

3 Pekeris Street

Entity Type: 16

Trademark Details

Filing Date

May 4, 2020

Registration Date

May 25, 2021

Published for Opposition

March 9, 2021

Goods & Services

Medical devices for delivery of medicated and pharmaceutical preparations, namely, implantable drug delivery pumps, drug delivery catheters, drug delivery patches sold without medication, subcutaneous drug delivery pumps, subcutaneous drug delivery patch pumps, refillable drug delivery pumps, and infusion drug delivery pumps; drug delivery device sold empty, namely, syringes, infusion drug delivery pumps; infusion sets; electromagnetic drug delivery apparatus for medical use; medical apparatus, namely, implantable ports; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and medical instruments for administering fluid, drugs, and nutrition, namely, infusion pumps, patch pumps being adherable subcutaneous drug delivery pumps, wearable medication injectors, wearable subcutaneous drug delivery pumps, and handheld medication injectors; medical syringes; medical devices in the nature of infusion pumps for drug infusion and for monitoring the infusion of drugs with integrated recorded software for transmission and receiving of drug infusion data, data related to the infusion pumps, drug infusion monitoring, filling and emptying of drug vials, and patient's behavior and reaction to drugs, sold as a unit therewith; drug delivery devices, namely, catheters, injection pen needles, injection needles, injection syringes and implantable subcutaneous drug delivery pumps; lancets; medical lancing devices for delivering medication, sold empty; drug eluting stents; bio-absorbable stents; synthetic stent grafts; medical diagnostic apparatus used to detect and measure the level of substances in body fluids; medical apparatus for measuring dosages and delivering pharmaceuticals, namely, infusion drug delivery pumps, subcutaneous drug delivery wearable pumps, subcutaneous drug delivery patch pumps, implantable drug delivery pumps and injection pens; electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; electronickinetic transdermal drug delivery control unit for the treatment of diseases

Pharmaceuticals, namely, pharmaceutical preparations for use in preventing and treating conditions, diseases, or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems; pharmaceutical preparations for use in prevention and treatment of allergies or allergic responses, metabolic disorders, psychiatric and emotional disorders, infection and infectious diseases, pain; drug delivery kits comprising dressings for medical, surgical, and veterinary use [ ; drug delivery agents, namely, transdermal patches sold with medication for use in the treatment of conditions, diseases or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems ]

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 25, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2022 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 9, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 9, 2022 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 11, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 11, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 25, 2021 FICR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jun 10, 2021 LIME
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 9, 2021 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Jun 9, 2021 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 9, 2021 APRE
REGISTERED-PRINCIPAL REGISTER
May 25, 2021 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Apr 23, 2021 LIMG
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 22, 2021 LIMN
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 9, 2021 PUBO
LIMITATION OF GOODS RECEIVED FROM IB
Feb 28, 2021 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2021 NONP
ASSIGNED TO LIE
Feb 2, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 2, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 2, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 2, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 2, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 1, 2021 TROA
REFUSAL PROCESSED BY IB
Jan 24, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 30, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 29, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 15, 2020 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 15, 2020 MAFR
NON-FINAL ACTION WRITTEN
Dec 14, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 10, 2020 REPR